Boston Scientific
BSXBoston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices used across various interventional medical specialties.
Earnings
Next report
Oct 28, 2026 (in 2 months)Financials
Q2 2026Income statement
Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
Profile
Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices used across various interventional medical specialties. The company focuses on less-invasive medical solutions that serve as alternatives to traditional surgery, aiming to improve patient outcomes while reducing healthcare costs. Its portfolio addresses complex conditions in cardiovascular, respiratory, digestive, oncological, neurological, and urological medicine.
A leading global medical technology provider specializing in category leadership through high-growth adjacencies and less-invasive procedural innovation.
FAQ
- What is Boston Scientific's market cap?
- Boston Scientific (BSX) has a market capitalization of $69.8B and trades on NYSE.
- What is Boston Scientific's revenue and profitability?
- Boston Scientific generated $21.0B in trailing twelve-month revenue with net income of $3.7B, representing a net margin of 17.5%. Gross margin stands at 69.9%. These figures are based on the Q2 2026 filing.
- Who are Boston Scientific's competitors?
- Boston Scientific's key competitors include Medtronic plc, Abbott Laboratories, Stryker Corporation, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Boston Scientific have?
- Boston Scientific's subsidiaries include Bolt Medical, Inc., SoniVie Ltd., Penumbra, Inc., and others.
- Where is Boston Scientific headquartered?
- Boston Scientific is headquartered in United States of America and employs approximately 48,000 people. It has been publicly traded since 1992.
